Lappe Mark Insider Trades

Insider Trading History

Track insider trading activity for Lappe Mark. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $67.2M 705,548 shares
Last Trade
Sep 16, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$223k 13,037 shares
$17.13
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $65.9M 692,511 shares
Last Trade
Sep 12, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$406k 26,963 shares
$15.05
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $63.4M 665,548 shares
Last Trade
Sep 10, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$129k 8,500 shares
$15.19
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $62.6M 657,048 shares
Last Trade
Sep 09, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$144k 9,500 shares
$15.21
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $61.7M 647,548 shares
Last Trade
Sep 06, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$398k 26,000 shares
$15.29
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $0 0 shares
Last Trade
May 30, 2024 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$4.83M 304,462 shares
$15.86
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $237M 2,486,192 shares
Last Trade
Feb 28, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.5k 60 shares
$25.02
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $237M 2,486,315 shares
Last Trade
Jan 24, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$111k 4,335 shares
$25.72
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $237M 2,490,587 shares
Last Trade
Jan 23, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$549k 21,665 shares
$25.36
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $9.52M 100,000 shares
Last Trade
Jan 03, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.33M 100,000 shares
$23.30
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $239M 2,513,006 shares
Last Trade
Dec 19, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$664k 26,000 shares
$25.55
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $244M 2,557,293 shares
Last Trade
Nov 17, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$725k 26,000 shares
$27.88
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $246M 2,581,271 shares
Last Trade
Oct 17, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$769k 26,000 shares
$29.59
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $13.8M 145,000 shares
Last Trade
Jan 15, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.88M 145,000 shares
$33.63
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $247M 2,590,252 shares
Last Trade
Dec 28, 2020 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$20.9M 500,000 shares
$41.76
$95.22
Inhibrx Biosciences
Inhibrx Biosciences INBX
Chief Executive Officer
Holding Value $47.6M 500,000 shares
Last Trade
Dec 28, 2020 Purchase (Gift)Shares transferred as a gift rather than bought or sold for cash.
$20.9M 500,000 shares
$41.76
$95.22
Royalty Pharma plc
Royalty Pharma plc RPRX
10% owner
Holding Value $275k 5,000 shares
Last Trade
May 20, 2009 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$54.97
Royalty Pharma plc
Royalty Pharma plc RPRX
10% owner
Holding Value $236M 4,292,136 shares
Last Trade
Oct 31, 2008 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$54.97
Royalty Pharma plc
Royalty Pharma plc RPRX
10% owner
Holding Value $235M 4,280,836 shares
Last Trade
Oct 29, 2008 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$54.97
Royalty Pharma plc
Royalty Pharma plc RPRX
10% owner
Holding Value $234M 4,256,436 shares
Last Trade
Oct 28, 2008 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$54.97

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up